Skip to main content

Advertisement

SpringerLink
Log in

Recent advances in the epidemiology of gout

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Gout remains among the most common of all inflammatory arthridities with an incidence that appears to have risen. Evidence is accumulating to support lifestyle and dietary factors, such as heavy consumption of beer and liquor as well as diets rich in meats and seafood as important gout risk factors. There is also a renewed interest in important associations between gout and other comorbidities like hypertension and cardiovascular disease. The importance of hyperuricemia on health considerations beyond the musculoskeletal system is an area worthy of even more study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Currie W: Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis 1979, 38:101–106.

    Article  PubMed  CAS  Google Scholar 

  2. Harris C, Lloyd C, Lewis J: The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995, 48:1153–1158.

    Article  PubMed  CAS  Google Scholar 

  3. Mikuls T, Farrar J, Bilker W, et al.: Gout epidemiology: results from the U.K. General Practice Research Database, 1990–1999. Ann Rheum Dis 2005, 64:267–272. Recently updated incidence and prevalence estimates based on data analysis from the electronic medical record of a sizable population of patients followed-up by generalists in the United Kingdom.

    Article  PubMed  CAS  Google Scholar 

  4. Klemp P, Stansfield S, Castle B, Robertson M: Gout is on the increase in New Zealand. Ann Rheum Dis 1997, 56:22–26.

    Article  PubMed  CAS  Google Scholar 

  5. Prior I, Rose B: Uric acid, gout and public health in the South Pacific. NZ Med J 1966, 65:295–300.

    CAS  Google Scholar 

  6. Benson V, Marano M: Current estimates from the National Health Interview Survey, 1992. Vital Health Stat 1992, 189:1–269.

    Google Scholar 

  7. Lawrence R, Helmick C, Arnett F, et al.: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41:778–799.

    Article  PubMed  CAS  Google Scholar 

  8. Lawrence R, Hochberg M, Kelsey J, et al.: Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989, 16:427–441.

    PubMed  CAS  Google Scholar 

  9. Abbott RD, Brand FN, Kannel WB, Castelli WP: Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 1988, 41:237–242.

    Article  PubMed  CAS  Google Scholar 

  10. Hall A, Barry P, Dawber T, McNamara P: Epidemiology of gout and hyperuricemia: a long-term population study. Am J Med 1967, 42:27–37.

    Article  PubMed  CAS  Google Scholar 

  11. O’Sullivan J: Gout in a New England town: a prevalence study in Sudbury, Massachusetts. Ann Rheum Dis 1972, 31:166–169.

    Article  PubMed  Google Scholar 

  12. Aromdee E, Michet C, Crowson C, et al.: Epidemiology of gout: is the incidence rising? J Rheumatol 2002, 29:2403–2406. An excellent epidemiologic study using the Rochester Epidemiology Cohort demonstrating variable rates of gout over time.

    Google Scholar 

  13. Mikuls T, Farrar J, Bilker W, et al.: Gout epidemiology: results from the U.K. General Practice Research Database, 1990–1999. Ann Rheum Dis 2005, 64:267–272.

    Article  PubMed  CAS  Google Scholar 

  14. Roubenoff R, Klag M, Mead L, et al.: Incidence and risk factors for gout in white men. JAMA 1991, 266:3004–3007.

    Article  PubMed  CAS  Google Scholar 

  15. Campion E, Glynn R, DeLabry L: Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987, 82:421–426.

    Article  PubMed  CAS  Google Scholar 

  16. Stewart O, Silman A: Review of UK data on the rheumatic diseases-4 Gout. Br J Rheumatol 1990, 29:485–488.

    Article  PubMed  CAS  Google Scholar 

  17. Fam A: Gout in the elderly: clinical presentation and treatment. Drugs Aging 1998, 13:229–243.

    Article  PubMed  CAS  Google Scholar 

  18. Bieber J, Terkeltaub R: On the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004, 50:2400–2414.

    Article  PubMed  Google Scholar 

  19. Fang J, Alderman M: Serum uric acid and cardiovascular mortality: NHANES I epidemiologic follow-up study, 1971–1992. JAMA 2000, 283:2404–2410. A secondary analysis of a large, highly generalizable, national survey that showed an increased risk for cardiovascular mortality among person with higher uric acid levels.

    Article  PubMed  CAS  Google Scholar 

  20. Hochberg M, Thomas J, Thomas D, et al.: Racial differences in the incidence of gout: the role of hypertension. Arthritis Rheum 1995, 38:628–632.

    Article  PubMed  CAS  Google Scholar 

  21. Burke G, Jacobs D, Sprafka J, et al.: Obesity and overweight in young adults: the CARDIA study. Prev Med 1990, 19:476–488.

    Article  PubMed  CAS  Google Scholar 

  22. US Renal Data System. USRDS 1999 annual data report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1999.

  23. Choi H, Atkinson K, Karlson E, et al.: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004, 350:1093–1103. An investigation using the Health Professionals Follow-up Study showing provocative associations of animal but not vegetable food sources of purines with gout

    Article  PubMed  CAS  Google Scholar 

  24. Garrel D, Verdy M, PetitClerc C, et al.: Milk- and soy-protein ingestion: acute effect on serum uric acid concentration. Am J Clin Nutr 1991, 53:665–669.

    PubMed  CAS  Google Scholar 

  25. Ghadirian P, Shatenstein B, Verdy M, Hamet P: The influence of dairy products on plasma uric acid in women. Eur J Epidemiol 1995, 11:275–281.

    Article  PubMed  CAS  Google Scholar 

  26. Blau L: Cherry diet control for gout and arthritis. Tex Rep Biol Med 1950, 8:309–311.

    PubMed  CAS  Google Scholar 

  27. Jacob R, Spinozzi G, Simon V, et al.: Consumption of cherries lowers plasma urate in healthy women. J Nutr 2003, 133:1826–1829.

    PubMed  CAS  Google Scholar 

  28. Choi H, Atkinson K, Karlson E, et al.: Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004, 363:1277–1281. Another paper using the Health Professionals Follow-up Study demonstrating higher risk for gout with increased exposure to beer and spirits but not with wine

    Article  PubMed  Google Scholar 

  29. Shadick N, Kim R, Weiss S, et al.: Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study. J Rheumatol 2000, 27:1708–1712. The development of gout due to high levels of lead exposure (saturine gout) is an association of long reported interest. This paper highlights a newer interest in gout risk after lower level lead exposure.

    PubMed  CAS  Google Scholar 

  30. Gibson T, Rodgers A, Simmonds H, Toseland P: Beer drinking and its effect on uric acid. Br J Rheumatol 1984, 23:203–209.

    Article  PubMed  CAS  Google Scholar 

  31. Choi HK, Curhan G: Beer, liquor, and wine consumption and serum uric acid level: The third National Health and Nutrition Examination Survey. Arthritis Rheum 2004, 51:1023–1029. In this large U.S. population-based survey, a significant and positive relationship was confirmed between high alcoholic beverage consumption and greater levels of uric acid.

    Article  PubMed  Google Scholar 

  32. Lin J-L, Tan D-T, Ho H-H, Yu C-C: Environmental lead exposure and urate excretion in the general population. Am J Med 2002, 113:563–568. Body lead burden increased a persons gout risk based on this cross-sectional Taiwanese data.

    Article  PubMed  CAS  Google Scholar 

  33. Langford HG, Blaufox MD, Borhani NO, et al.: Is thiazideproduced uric acid elevation harmful: analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 1987, 147:645–649.

    Article  PubMed  CAS  Google Scholar 

  34. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Anti-hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981–2987.

    Article  Google Scholar 

  35. Burack DA, Griffith BP, Thompson ME, Kahl LE: Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med 1992, 92:141–146.

    Article  PubMed  CAS  Google Scholar 

  36. Chapman JR, Harding NGL, Griffiths D, Morris PJ: Reversibility of cyclosporin nephrotoxicity after three months’ treatment. Lancet 1985, 325:128–130.

    Article  Google Scholar 

  37. Clive DM: Renal transplant-associated hyperurecemia and gout. J Am Soc Nephrol 2000, 11:974–979.

    PubMed  CAS  Google Scholar 

  38. Lin HY, Rocher LL, McQuillan MA, et al.: Cyclosporineinduced hyperuricemia and gout. N Engl J Med 1989, 321:287–292.

    Article  PubMed  CAS  Google Scholar 

  39. Ahn KJ, Kim YS, Lee HC, et al.: Cyclosporine-induced hyperuricemia after renal transplant: clinical characteristics and mechanisms. Transplant Proc 1992, 24:1391–1392.

    PubMed  CAS  Google Scholar 

  40. Caspi D, Lubart E, Graff E, et al.: The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000, 43:103–108.

    Article  PubMed  CAS  Google Scholar 

  41. Gertler MM, Gam SM, Levine SA: Serum uric acid in relation to age and physique in health and coronrary heart disease. Ann Intern Med 1951, 34:1421–1431.

    PubMed  CAS  Google Scholar 

  42. Scott JT, Sturge RA: The effect of weight loss on plasma and urinary uric acid and lipid levels. J Clin Chem Clin Biochem 1976, 14:319.

    Google Scholar 

  43. St-Onge MP, Keller KL, Heymsfield SB: Changes in childhood food consumption patterns: a cause for concern in light of increasing body weights. Am J Clin Nutr 2003, 78:1068–1073.

    PubMed  CAS  Google Scholar 

  44. Bedir A, Topbas M, Tanyeri F, et al.: Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 2003, 44:527–536. This study provides a provocative glimpse into a potential biological mechanism that could help explain the association between obesity and gout.

    Article  PubMed  CAS  Google Scholar 

  45. Denzer C, Muche R, Mayer H, et al.: Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome. J Pediatr Endocrinol Metab 2003, 16:1225–1232.

    PubMed  CAS  Google Scholar 

  46. Nakanishi N, Tatara K, Nakamura K, Suzuki K: Risk factors for the incidence of hyperuricaemia: a 6-year longitudinal study of middle-aged Japanese men. Int J Epidemiol 1988, 28:888–893.

    Article  Google Scholar 

  47. Breckenridge A: Hypertension and hyperuricaemia. Lancet 1966, 1:15–18.

    Article  PubMed  Google Scholar 

  48. Gavin AR, Struthers AD: Hyperuricemia and adverse outcomes in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs 2003, 3:309–314.

    Article  PubMed  Google Scholar 

  49. Feig DI, Johnson RJ: Hyperuricemia in childhood primary hypertension. Hypertension 2003, 42:247–252.

    Article  PubMed  CAS  Google Scholar 

  50. Tykarski A: Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron 1991, 59:364–368.

    Article  PubMed  CAS  Google Scholar 

  51. Sanchez-Lozada LG, Tapia E, Avila-Casado C, et al.: Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 2002, 283:F1105–1110. An elegant physiologic study suggesting that hyperuicemia in rats may play a direct pathogenic role as a mechanism that could potentially explain a documented association of gout with hypertension in man.

    PubMed  Google Scholar 

  52. Bengtsson C, Lapidus L, Stendahl C, Waldenstrom J: Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 1988, 224:549–555.

    Article  PubMed  CAS  Google Scholar 

  53. Freedman DS, Williamson DF, Gunter EW, Byers T: Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995, 141:637–644.

    PubMed  CAS  Google Scholar 

  54. Levine W, Dyer AR, Shekelle RB, et al.: Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989, 42:257–267.

    Article  PubMed  CAS  Google Scholar 

  55. Woo J, Swaminathan R, Cockram C, et al.: Association between serum uric acid and some cardiovascular risk factors in a Chinese population. Postgrad Med J 1994, 70:486–491.

    Article  PubMed  CAS  Google Scholar 

  56. Brand FN, McGee DL, Kannel WB, et al.: Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol 1985, 121:11–18.

    PubMed  CAS  Google Scholar 

  57. Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7–13.

    PubMed  CAS  Google Scholar 

  58. Gelber AC, Klag MJ, Mead LA, et al.: Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. Arch Intern Med 1997, 157:1436–1440.

    Article  PubMed  CAS  Google Scholar 

  59. Persky VW, Dyer AR, Idris-Soven E, et al.: Uric acid: a risk factor for coronary heart disease? Circulation 1979, 59:969–977.

    PubMed  CAS  Google Scholar 

  60. Rathmann W, Funkhouser E, Dyer AR, Roseman JM: Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Ann Epidemiol 1998, 8:250–261.

    Article  PubMed  CAS  Google Scholar 

  61. Høieggen A, Alderman MH, Kjeldsen SE, et al.: The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004, 65:1041–1049. A randomized controlled clinical trial of Losartan demonstrating a modest uricosuric effect and a perceived resultant lower risk for cardiovascular events.

    Article  PubMed  Google Scholar 

  62. Lehto S, Niskanen L, Ronnemaa T, Laakso M: Serum uric acid is a strong predictor of stroke in patients with non-insulindependent diabetes mellitus. Stroke 1998, 29:635–639.

    PubMed  CAS  Google Scholar 

  63. Anker SD, Doehner W, Rauchhaus M, et al.: Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003, 107:1991–1997. This study suggests important associations of hyperuricemia with congestive heart failure.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 820 Faculty Office Tower, 510 20th Street South, 35294-3408, Birmingham, AL, USA

    Kenneth G. Saag MD, MSc

Authors
  1. Kenneth G. Saag MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ted R. Mikuls MD, MSPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saag, K.G., Mikuls, T.R. Recent advances in the epidemiology of gout. Curr Rheumatol Rep 7, 235–241 (2005). https://doi.org/10.1007/s11926-996-0045-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-996-0045-z

Keywords

Search

Navigation